Nivolumab in Children and Adults With Nasopharyngeal Carcinoma
Conditions
Nasopharyngeal Carcinoma · Nasopharyngeal Cancer · Nasopharyngeal Neoplasms · Nasopharynx Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Uniklinik RWTH Aachen, Department of Internal Medicine, Aachen, Germany
Uniklinik RWTH Aachen, Division of Pediatric Hematology, Oncology, Stem Cell Transplantation, Aachen, Germany
Department of Pediatric Oncology and Hematology, Charité University Medicine Berlin, Berlin, Germany
Evangelisches Klinikum Bethel, Children's Hospital, Bielefeld, Germany
Department of Pediatric Hematology and Oncology, University Hospital, Bonn, Germany
Department of Otorhinolaryngology, Head and Neck Surgery, University of Cologne, Cologne, Germany
Children's Hospital, Carl-Thiem Klinikum Cottbus, Cottbus, Germany
Clinic for Children and Adolescent Medicine, Klinikum Dortmund, Dortmund, Germany
Department of Internal Medicine, Klinikum Dortmund, Dortmund, Germany
Department of Pediatrics, University Hospital, Technische Universität Dresden, Dresden, Germany
Department fo Radiotherapy, University Hospital, Erlangen, Germany
Contact: Study coordinator (Marlen Haderlein, MD) · st-studiensekretariat@uk-erlangen.de · +49-9131-8533405Department of Pediatrics, University Hospital Erlangen, Erlangen, Germany
Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany
Department of Pediatric Hematology and Oncology, University Hospital Essen, Essen, Germany
Contact: Study coordinator (Stefan Schönberger, MD) · Stefan.Schoenberger@uk-essen.de · +49-201-723-85190.Department of Pediatrics, University Hospital, Frankfurt, Germany
Department of Pediatric Hematology/Oncology, University Hospital Freiburg, Freiburg im Breisgau, Germany
Contact: Study coordinator (Simone Hettmer, MD) · simone.hettmer@uniklinik-freiburg.de · +49-761-270-46940Department of Pediatric Oncology, Justus-Liebig University of Giessen, Giessen, Germany
Department of Pediatric Oncology, University Hospital, Göttingen, Germany
Department of Pediatric Hematology/Oncology, University Medicine Greifswald, Greifswald, Germany
Contact: Study coordinator (Karoline Ehlert, MD) · karoline.ehlert@med.uni-greifswald.de · +49-3834-866325Universitätsklinikum Halle, Klinik für Pädiatrie I, Halle, Germany
Department of Otorhinolaryngology, University Medical Center Hamburg-Eppendorf,, Hamburg, Germany
Department of Pediatric Oncology, University Children's Hospital, Hamburg, Germany
Department of Otorhinolaryngology, Jena University Hospital, Jena, Germany
Department of Pediatric Oncology, University Hospital Kiel, Kiel, Germany
Department of Pediatrics, University Hospital Mageburg, Magdeburg, Germany
Pediatric Hematology/Oncology, University Medicine Mainz, Mainz, Germany
Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Mannheim,, Mannheim, Germany
Department of Pediatric Hematology and Oncology, University Children's Hospital, Münster, Germany
Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University Hospital, Regensburg, Germany
Contact: Study coordinator (Marcus Jakob, MD) · Marcus.Jakob@klinik.uni-regensburg.de · +49-941-944-2101Universitätsklinikum Tübingen, Klinik für Pädiatrie I, Tübingen, Germany
Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University Children's Hospital, University of Würzburg, Würzburg, Germany
Study leads
Udo Kontny, MD
Principal Investigator
Uniklinik RWTH Aachen